Vestra en es it fr

Vestra Brand names, Vestra Analogs

Vestra Brand Names Mixture

  • Reboxetine [INN]
  • (+/-)-(2R*)-2-((alphaR*)-alpha-(o-Ethoxyphenoxy)benzyl)morpholine

Vestra Chemical_Formula


Vestra RX_link

No information avaliable

Vestra fda sheet

Vestra msds (material safety sheet)

Vestra Synthesis Reference

Lin, KS & Ding, YS (2004) Chirality 16:475-481

Vestra Molecular Weight

313.391 g/mol

Vestra Melting Point

170-171 oC (Mesylate salt)

Vestra H2O Solubility

8 mg/mL (Mesylate salt)

Vestra State


Vestra LogP

0.48 (Ding, YS et al. J. Neruochem. 94:1471 (2005))

Vestra Dosage Forms


Vestra Indication

For the treatment of clinical depression.

Vestra Pharmacology

Reboxetine is a selective noradrenaline reuptake inhibitor (NaRI), the first

Vestra Absorption

Reboxetine is rapidly and extensively absorbed following oral administration.

Vestra side effects and Toxicity

Reports of seizures (rare) have been reported

Vestra Patient Information

No information avaliable

Vestra Organisms Affected

Humans and other mammals